{"name":"Crossject","slug":"crossject","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxPd2lVcEozT00wSGNqczNHdnVJUHdKVHlYNUVBQ1d2azAxLU9yOVl1dUVLX0NLRlloNW8yRDZwMG9lSDNzVWtKTkJlYmZuZkZkNXF4N1ltdTBRcm4za01MR3U2cDJZbjNSM211V2hFZXRFdmVsRDd2TUZvSmRPSFllbVF6b1hPazBDRWRSNjBzZGozcnAxLUZwRE5GaUlMdnJxSUxLdmYxSTJJa0lxNWxvYnhsSm1TWjJieTNJSXA5ZXlobmotc3JjQmctb3lXZw?oc=5","date":"2026-04-02","type":"pipeline","source":"vocal.media","summary":"Needle-free Drug Delivery Technology Market Outlook: Patient-Friendly Innovation and Growth Opportunities - vocal.media","headline":"Needle-free Drug Delivery Technology Market Outlook: Patient-Friendly Innovation and Growth Opportunities","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxNTE9rcV9OdncxV3ViaUFhSkZOaTZ0Sm1QLTlITmdZbW1BRFE3clNiRVpISjRTcjd6NkZyRWhwalIxcUQ2QU1TcXV3OTZteTdYaGVLYTFxYV9EdU9FZU5WRFhTbHg0ZWVVY2Jxc2dWV2RuSnNVSFVXRXo4Nk9fMUltdlBsdTdMSlREVGhOcngxaGlZczZhcGkwVkZOR2wxc1Y2MmVOY1R6U014REp4TnM4WTdGT0x0S0NCUkplUGJvSGZOaEVMeF9KcGNn?oc=5","date":"2026-03-25","type":"pipeline","source":"GlobeNewswire","summary":"CROSSJECT appoints Lionel Seltz as Chief Financial Officer - GlobeNewswire","headline":"CROSSJECT appoints Lionel Seltz as Chief Financial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAJBVV95cUxQWE9DQTg1YVdPQ0RjVm53eU4xeldrXzlzSWRhUnBJbDIyOGg5RVZNVW8zN0p4ZDVLaVVtakNjT281TUgtWjFONEJRUkJaWDN0czRzXy1KM2FKSVRDTDlWSHhidWVnb0ZhOXc4OEZsbTB6WktHNjl1TVA0NlpFZTMwOEZ3RWZiSEpYQi1tNzFWUzNUWGZtaXBnTnJ2eUtPTmVJRXpzVXVPRTZyclJ5a3pKOEt2eTRxOGxFb2lPSElIeEI2V09kcWxEV3BLYXFxZ3lIR2pjS3pac3Q1MEw5eXIyQ1Q5MXZmZElFRDJBNWUtSm9KVXg2MmJBSnZLQldQYmJWNmk0N0g1SHd1aGZqalQySkNzVWxya2paVGE1NXRoa2M4QllPYlRHdzlQZzk?oc=5","date":"2026-03-25","type":"pipeline","source":"GlobeNewswire","summary":"CROSSJECT publishes its 2025 financial results and confirms - GlobeNewswire","headline":"CROSSJECT publishes its 2025 financial results and confirms","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNdjRPdUVOTDBKOHRVR203V2I4NHN2a21xZ1VkSVB4LVZrX3BpMjVycmxNOTZTVjg1QmxlZHpfY05GWkRYREpVM2JoVXY1bWltQ2hpNTlqT21iMndXT3kwZ1U4WWFHenBRVkpqQU1BaWVFTHBBLVF2RHdZREZubkpaUmhIcXhYcW5JanlvVHduRkhJSDE0bE9FcnNDN1ZiaWVZ?oc=5","date":"2026-03-12","type":"pipeline","source":"Yahoo Finance","summary":"Pharmaceutical and Biotechnology Royalty Rates Agreements Report and Directory 2026: Insights Into 1,567 Licensing Transactions by Company A-Z, Therapeutic Area, Technology, Headline Value - Yahoo Fin","headline":"Pharmaceutical and Biotechnology Royalty Rates Agreements Report and Directory 2026: Insights Into 1,567 Licensing Trans","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxQcW5jMThlcDRxSnlUTHo5VmVIQXMtV1F5VUJ1M3RVR2Y2cGZVaGtpb0RSdGhoX0FTNENieFFWbzUwLThXTnhabE5jZWRfdFpkSHFLc3pwcFdrZmFfVWNxTHpRcTQyWDBCZVhtRHJlbHJZUXZvZ0Y2aG1RSXdscjR0ZWU4SHJpeE1CQXpwLTR2TzY1Q1hHcmdNb0lYV180bEJRUnYzSUpFNlZZZmtfY0tvQk42QXRYc0RQMjY3SDhmbmJiUU1xNFNuaDBJWGQ0WU90M0t5bjNBb2owelZma3gxUGxtWmpfaVRwUGpVZHhHd1VYMDlh0gH6AUFVX3lxTFBfTmxRVzEzel9ETU9vOVlqS2NrdnFUdE1NTWw3TjJhSFBmUTg1N056R25fN1RpQjJpQnZGb1hvWnNPdDR0dFRkdGxLOXJkVDdBVFpIVDN6dDlOUWsweXo5YWVoU0JTRnBBTEZzT29Takx0RnNDaWl4WnZWVWg5d3QtUVFGNDN4QmlseUtHdUJzNmJPTGNiWldhRUNueldVemstbm5hVXk0ZUdfV29zdU9VMzhYbE1MZWZUUkNzS2NVZm9pLW9pZFVxZXUxNkN4b2pfWmo3OVFvdElIVi1na1FObENfVFIydGcwUmg1UHl6WTZQdWdBX3gyZGc?oc=5","date":"2026-02-02","type":"pipeline","source":"The Manila Times","summary":"CROSSJECT announces initiation of coverage of its stock by Portzamparc (BNP Paribas Group) - The Manila Times","headline":"CROSSJECT announces initiation of coverage of its stock by Portzamparc (BNP Paribas Group)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxQcFFBWk5mUjdVaXpNdkxtc3BDRXMwQlVIWkRSckpacXZIR3dPRmNYV3FYbGV0OVJxdDM0eXJpLWFxa2NFYlRmSEwwaUdPXzZJRHJzTURMZVdpTHRfVEhOQVlQakdiM3RWOG9EZS1VVnhoWkNvbkZwZzJDSTdHX1RKdEQxdlBmTnZiTHREUmc2SDkxNFFubjN4Q1VKTmZReVZUWm9IR05yZFE2b1VISDFyYUJ2ZmotZktEc3hYLWNWdG4yOEc1?oc=5","date":"2025-06-06","type":"earnings","source":"Seeking Alpha","summary":"Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More Upside - Seeking Alpha","headline":"Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More Upside","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNVFVVN3F3RW82Y0l4QUJMRlhCSEw5VGNiX1puYjN0SVNiWVhHVzVaNU0xWkVlU1Ziejd5aGlWU3JsSnZXS0F4cHBjdGNBWl9uTmZobm1uNDl0cW82emowTDFsSUhzQktlcUoyUWFoUmNTTXY1WUpxRTN0RnhvMnFTV2o2WkZlNW81U3I2RjZHZHV6VTBfX3hZVVFraDdfdVhyVUJyWXQ5MGZ6SXlTeWd1SzRnQjBBNU01U0NkQVBR?oc=5","date":"2024-07-12","type":"pipeline","source":"Pharmaceutical Technology","summary":"Crossject secures funding from French Government for needle-free platform - Pharmaceutical Technology","headline":"Crossject secures funding from French Government for needle-free platform","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2018-10-26","type":"pipeline","source":"openPR.com","summary":"Needle-free Injection Systems Market Expected to reach $23,116 - openPR.com","headline":"Needle-free Injection Systems Market Expected to reach $23,116","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgJBVV95cUxNN1lmM0VGWmVEWERFd0FTUkVIZmk3ckpwUU1TUXVDcHIyUmxkSDdwUEIwaEM2eEFjVS10NkVxS3JCQnZ1cHZVZHU2SXUzV2prSFlwcGFuMktRUkJ0eVl4X0dSblFkRHB2NTgtMWo2a0VLWHBZalI1U1B1cEdoRC12UmRiM3hNV2ZtWGhCcWFTcFE0cjktUF9ITEVMeFg1Z0NKdkItRFdaT2VpODBDb0NFRmJob05td29vYVJqanJaWDhGaVpDazJFSTB3ZFJUV3dESzlDbXljV0hfV044ZnJVeGdwbW41bEVoX2dpOTNfLWx6Z1ZTU3VSQk1BZ0hqVkVGbDFkM2JQOFFGWEl4X3VDbGRiLXhxSjZjbGl4dldpWWZTM0lxLUEzeU4zbnlCUGRQZWkxMThCa2U2eUZMdHNxV2lFNlpBdVpwWlc5VGdR?oc=5","date":"2018-10-23","type":"pipeline","source":"openPR.com","summary":"Needle-free Injection Systems Market to 2025 - Top Companies - openPR.com","headline":"Needle-free Injection Systems Market to 2025 - Top Companies","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}